Results for tag: "Pralatrexate"

Pralatrexate is a chemotherapy drug used to treat peripheral T-cell lymphoma (PTCL). It is a folate analog inhibitor, meaning it works by blocking the action of folate, a vitamin essential for cell growth. Pralatrexate is administered intravenously and is usually given in combination with other drugs. It is approved by the US Food and Drug Administration (FDA) for the treatment of relapsed or refractory PTCL in adults. The Pralatrexate market is composed of a variety of companies, including pharmaceutical companies, biotechnology companies, and generic drug manufacturers. These companies are involved in the research, development, manufacturing, and marketing of Pralatrexate. Pharmaceutical companies are responsible for the development of new drugs, while biotechnology companies focus on the development of biologics, such as monoclonal antibodies. Generic drug manufacturers produce generic versions of Pralatrexate, which are typically less expensive than the brand-name version. Some companies in the Pralatrexate market include Pfizer, Amgen, Genentech, Novartis, and Teva Pharmaceuticals. Show Less Read more